Breaking News Instant updates and real-time market news.

HZNP

Horizon Pharma

$19.52

0.79 (4.22%)

, ESRX

Express Scripts

$70.57

0.51 (0.73%)

08:57
10/11/16
10/11
08:57
10/11/16
08:57

Horizon Pharma sees FY16 adjusted net sales at low end of $1.02B-$1.05B

Consensus $1.03B. Horizon Pharma (HZNP) is providing estimates of certain Q3 results, confirming expected net sales on a non-GAAP adjusted basis at the low end of its previously announced full-year net sales guidance range and revising its full-year 2016 adjusted EBITDA guidance range, reflecting higher fourth-quarter investment spending. The additional operating expenses reflect strategic investments the company is making to support future growth opportunities, particularly as it transitions its business mix toward orphan disease medicines and builds a more durable primary care business, Horizon stated in a regulatory filing. The company anticipates, on a GAAP basis including the previously announced $65M settlement with Express Scripts (ESRX) as a one-time reduction in GAAP net sales, its full-year 2016 net sales will be approximately $960M. Excluding the $65M settlement, the company now expects that net sales on a non-GAAP adjusted basis will be at the low end of its previously announced full-year net sales guidance range of $1.025B-$1.05B, or approximately $1.025B. The exclusion of the $65M settlement from GAAP net sales guidance is the only adjustment reflected in Horizon Pharma's full-year 2016 non-GAAP adjusted net sales guidance. The company is revising its full-year 2016 adjusted EBITDA guidance range as the result of expected net sales at the low end of its non-GAAP adjusted net sales guidance range and anticipated higher investment spending in the fourth quarter of 2016 and now expects adjusted EBITDA to be in the range of $450M-$460M, prior range was $495M-$510M. The company's full-year 2016 guidance does not include the previously announced expected acquisition of Raptor Pharmaceutical Corp.

HZNP

Horizon Pharma

$19.52

0.79 (4.22%)

ESRX

Express Scripts

$70.57

0.51 (0.73%)

  • 26

    Oct

  • 06

    Nov

  • 14

    Dec

HZNP Horizon Pharma
$19.52

0.79 (4.22%)

08/02/16
BMOC
08/02/16
NO CHANGE
BMOC
Outperform
Horizon Pharma scored 'important win' with CVS, says BMO Capital
BMO Capital analyst Gary Nachman said Horizon Pharma (HZNP) securing covered status for Duexis and Vimovo with CVS/Caremark (CVS) is an "important win" for the drugmaker that demonstrates it is improving its execution on the managed care front. While Express Scripts (ESRX) still has Duexis and Vimovo on its exclusion list for 2017, Horizon indicated that it is still in discussions that have been "constructive," noted Nachman, who keeps an Outperform rating on Horizon shares.
09/13/16
BMUR
09/13/16
NO CHANGE
Target $32
BMUR
Buy
Horizon Pharma acquisition a positive, says Brean Capital
Brean Capital analyst Difei Yang said she is positive on Horizon Pharma's (HZNP) deal for Raptor Pharmaceuticals (RPTP). The analyst cited Horizon executing on its transformative strategy into an orphan disease company, the reasonable price paid for the company, and the moderate growth opportunities for synergies between the two. Yang reiterated her Buy rating and raised her price target to $32 from $30 on Horizon Pharma shares.
09/30/16
JMPS
09/30/16
NO CHANGE
JMPS
Horizon Pharma patent loss immaterial, says JMP Securities
After the U.S. Patent and Trademark Office ruled that Horizon Pharma's '215 patent for Ravicti is unpatentable, JMP Securities analyst Donald Ellis says the news is not material. He says that Ravicti still has orphan drug exclusivity until 2020, and that the company has five other patents on the drug that will last until 2032. He recommends buying Horizon on any weakness.
10/03/16
BMOC
10/03/16
NO CHANGE
BMOC
Horizon Pharma added to US Small Cap Fundamental List at BMO Capital
ESRX Express Scripts
$70.57

0.51 (0.73%)

08/09/16
LEER
08/09/16
NO CHANGE
Target $110
LEER
Outperform
Leerink remains positive on CVS Health long-term fundamentals
Leerink analyst David Larsen continues to be positive on CVS' (CVS) long-term fundamentals. The analyst notes that the company is having a successful 2017 selling season, with a retention rate higher than what it was last year, and says its Q3 should benefit from a number of break-even generics. Further, Larsen says the company is being more aggressive than Express Scripts (ESRX) with regards to formulary management, and believes that if CVS provides a 5-year outlook in December, shares will likely rally. Larsen reiterates an Outperform rating and $110 rating on CVS' shares.
08/15/16
LEER
08/15/16
NO CHANGE
LEER
Outperform
Leerink more positive on CVS after Formulary exclusions lists
Leerink analyst David Larsen says he's incrementally more positive on CVS Health (CVS) after the company and Express Scripts (ESRX) published their 2017 National Preferred Formulary exclusions lists. CVS is being more aggressive about using bio-similar products and has excluded about 10 products due to hyperinflation trends, Larsen tells investors in a research note. Express Scripts is excluding around 85 products in 2017, which is almost half of the 153 products being excluded by CVS, the analyst writes. He keeps an Outperform rating on CVS and a Market Perform ration on Express Scripts.
08/29/16
LEER
08/29/16
NO CHANGE
LEER
EpiPen price is Mylan's issue, says Leerink
Leerink analyst David Larsen says the recent weakness in pharmacy benefit managers and the drug distribution group is "overdone," as he believes Mylan (MYL) has been taking the vast majority of the pricing increases that have occurred with EpiPen, not the pharmacy benefit managers and distributors. Further, the analyst estimates that Cardinal Health (CAH) has a "fee-for-service" deal with EpiPen, which means that there may be no benefit to the company for any price increase that occurs, and notes that Express Scripts (ESRX) gives back 80%-90% of EpiPen rebates to their plan customers. Larsen would be a buyer of CVS Health (CVS) on weakness.
10/05/16
UBSW
10/05/16
INITIATION
Target $76
UBSW
Neutral
Express Scripts initiated with a Neutral at UBS
Target $76.

TODAY'S FREE FLY STORIES

BOX

Box

$16.98

-0.03 (-0.18%)

12:17
04/25/17
04/25
12:17
04/25/17
12:17
Hot Stocks
Box introduces flexible, subscription-based pricing for Box Platform »

Box announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
04/25/17
04/25
12:17
04/25/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
04/25/17
04/25
12:16
04/25/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$30.03

-0.19 (-0.63%)

, CNCE

Concert Pharmaceuticals

$16.08

0.38 (2.42%)

12:13
04/25/17
04/25
12:13
04/25/17
12:13
Hot Stocks
Aclaris Therapeutics given $5 price target in short report »

Art Doyle tweeted out to…

ACRS

Aclaris Therapeutics

$30.03

-0.19 (-0.63%)

CNCE

Concert Pharmaceuticals

$16.08

0.38 (2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 06

    Jun

PG

Procter & Gamble

$90.00

0.4501 (0.50%)

, PEP

PepsiCo

$114.43

0.11 (0.10%)

12:12
04/25/17
04/25
12:12
04/25/17
12:12
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$90.00

0.4501 (0.50%)

PEP

PepsiCo

$114.43

0.11 (0.10%)

BA

Boeing

$183.29

1.23 (0.68%)

UTX

United Technologies

$116.85

0.53 (0.46%)

TMO

Thermo Fisher

$158.74

1.4 (0.89%)

GD

General Dynamics

$191.83

-0.085 (-0.04%)

ANTM

Anthem

$172.26

3.845 (2.28%)

NOC

Northrop Grumman

$248.59

-0.55 (-0.22%)

WM

Waste Management

$74.54

0.44 (0.59%)

IR

Ingersoll-Rand

$85.18

0.99 (1.18%)

DPS

Dr Pepper Snapple

$98.25

-0.0006 (-0.00%)

HES

Hess Corp.

$48.27

0.61 (1.28%)

WYN

Wyndham

$92.30

0.505 (0.55%)

FLIR

FLIR Systems

$37.24

0.87 (2.39%)

NDAQ

Nasdaq

$70.45

0.54 (0.77%)

STT

State Street

$80.63

0.84 (1.05%)

APH

Amphenol

$72.38

0.45 (0.63%)

ROK

Rockwell Automation

$159.38

2.43 (1.55%)

BAX

Baxter

$53.14

-0.315 (-0.59%)

NSC

Norfolk Southern

$117.09

0.04 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 02

    May

  • 03

    May

  • 06

    May

  • 11

    May

  • 17

    May

  • 18

    May

  • 31

    May

  • 06

    Jun

  • 15

    Jun

CHRW

C.H. Robinson

$77.59

1.05 (1.37%)

, CMG

Chipotle

$472.00

3.21 (0.68%)

12:11
04/25/17
04/25
12:11
04/25/17
12:11
Earnings
Notable companies reporting after market close »

Notable companies…

CHRW

C.H. Robinson

$77.59

1.05 (1.37%)

CMG

Chipotle

$472.00

3.21 (0.68%)

COF

Capital One

$85.41

0.725 (0.86%)

DFS

Discover

$67.05

0.135 (0.20%)

EW

Edwards Lifesciences

$98.36

0.4 (0.41%)

ILMN

Illumina

$180.20

4.91 (2.80%)

JNPR

Juniper

$28.15

-0.125 (-0.44%)

SYK

Stryker

$135.76

1.31 (0.97%)

T

AT&T

$40.00

-0.02 (-0.05%)

TSS

TSYS

$54.40

0.59 (1.10%)

TXN

Texas Instruments

$81.08

1.27 (1.59%)

UHS

Universal Health

$121.51

0.605 (0.50%)

WYNN

Wynn Resorts

$115.57

-0.33 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 03

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 09

    May

  • 16

    May

  • 17

    May

  • 25

    May

  • 31

    May

  • 06

    Jun

  • 08

    Jun

MLCO

Melco Resorts & Entertainment

$20.75

0.2 (0.97%)

12:11
04/25/17
04/25
12:11
04/25/17
12:11
Options
Bullish flow in Melco Resorts and Entertainment »

Bullish flow in Melco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$34.02

1.41 (4.32%)

12:06
04/25/17
04/25
12:06
04/25/17
12:06
Options
Sarepta call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$66.54

0.44 (0.67%)

, PRGO

Perrigo

$67.28

0.23 (0.34%)

12:05
04/25/17
04/25
12:05
04/25/17
12:05
Hot Stocks
Greenlight goes long Perrigo, Conduent, closes Signet short »

David Einhorn's…

SIG

Signet Jewelers

$66.54

0.44 (0.67%)

PRGO

Perrigo

$67.28

0.23 (0.34%)

GM

General Motors

$33.85

-0.065 (-0.19%)

RAD

Rite Aid

$3.89

0.1558 (4.18%)

WBA

Walgreens Boots Alliance

$84.28

0.25 (0.30%)

CNDT

Conduent

$15.94

-0.02 (-0.13%)

LYB

LyondellBasell

$87.27

0.75 (0.87%)

RES

RPC, Inc.

$17.62

0.07 (0.40%)

AER

AerCap

$45.40

0.31 (0.69%)

BAYRY

Bayer

$118.05

4.95 (4.38%)

CNX

CONSOL

$15.59

0.19 (1.23%)

AAPL

Apple

$143.64

1.37 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 28

    Apr

  • 28

    Apr

  • 02

    May

  • 02

    May

  • 03

    May

  • 09

    May

  • 09

    May

  • 31

    May

  • 26

    Jun

MCD

McDonald's

$140.45

6.215 (4.63%)

11:58
04/25/17
04/25
11:58
04/25/17
11:58
Hot Stocks
Breaking Hot Stocks news story on McDonald's »

McDonald's says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 31

    May

AAPL

Apple

$143.64

1.37 (0.96%)

11:58
04/25/17
04/25
11:58
04/25/17
11:58
Hot Stocks
Einhorn's Greenlight continues to like Apple shares »

David Einhorn's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

11:55
04/25/17
04/25
11:55
04/25/17
11:55
General news
Treasury's bill auctions were mixed with the shorter tranche outperforming »

Treasury's bill…

S

Sprint

$8.85

0.135 (1.55%)

11:51
04/25/17
04/25
11:51
04/25/17
11:51
Options
Sizable put buyer in Sprint »

Sizable put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

11:50
04/25/17
04/25
11:50
04/25/17
11:50
General news
U.S. equities extended their rally »

U.S. equities extended…

SIG

Signet Jewelers

$66.07

-0.03 (-0.05%)

11:47
04/25/17
04/25
11:47
04/25/17
11:47
Technical Analysis
Signet Jewelers ticks up off recent lows »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$878.93

19.98 (2.33%)

11:46
04/25/17
04/25
11:46
04/25/17
11:46
Options
Alphabet Class A call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$140.47

6.24 (4.65%)

11:46
04/25/17
04/25
11:46
04/25/17
11:46
Hot Stocks
Breaking Hot Stocks news story on McDonald's »

McDonald's says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 31

    May

SIG

Signet Jewelers

$66.12

0.02 (0.03%)

11:39
04/25/17
04/25
11:39
04/25/17
11:39
Periodicals
Greenlight closed short position in Signet Jewelers in Q1, Bloomberg reports »

Bloomberg cites the Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:37
04/25/17
04/25
11:37
04/25/17
11:37
General news
52-Week Bill Auction Bid/Cover data reported »

52-Week Bill Auction…

MDT

Medtronic

$81.70

1.05 (1.30%)

11:36
04/25/17
04/25
11:36
04/25/17
11:36
Hot Stocks
Medtronic announces outcomes from VeClose trial and data from WAVES study »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 06

    Jun

11:36
04/25/17
04/25
11:36
04/25/17
11:36
General news
52-Week Bill Auction Total Amount data reported »

52-Week Bill Auction…

11:36
04/25/17
04/25
11:36
04/25/17
11:36
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

PRGO

Perrigo

$66.12

-0.93 (-1.39%)

11:35
04/25/17
04/25
11:35
04/25/17
11:35
Periodicals
Einhorn's Greenlight reveals new stake in Perrigo, Bloomberg reports »

Bloomberg cites the Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
04/25/17
04/25
11:35
04/25/17
11:35
General news
Treasury Option Action: a round of put buying on bonds »

Treasury Option Action: a…

AKS

AK Steel

11:33
04/25/17
04/25
11:33
04/25/17
11:33
Hot Stocks
AK Steel sees Q2 shipments flat compared to Q1 »

AK Steel said it expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.